DOH Clinical Costing Roadmap 2026 (V2): Key Updates & Compliance Changes
section image
Mohammed Sheheen
April 4, 2026
DOH Clinical Costing Roadmap 2026 (V2): Key Updates & Compliance Changes image

The Department of Health (DOH) in Abu Dhabi continues to advance its clinical costing framework as part of its broader strategy to enable transparency, efficiency, and value-based healthcare delivery.

Following the initial rollout of clinical costing standards, the Clinical Costing Roadmap 2026 (Version 2.0) introduces refined guidelines, enhanced validation mechanisms, and updated technical requirements for healthcare providers.

This update represents a progression from foundational implementation toward standardized, accurate, and auditable patient-level costing systems (PLICS).

Background: Clinical Costing Roadmap (2024–2025)

The earlier phase of the clinical costing initiative established the foundation for structured cost reporting across healthcare providers in Abu Dhabi.

Key elements introduced during this phase included:

  • Clinical Costing Standard (Version 1.0)
  • Regulatory guidelines for cost allocation
  • Initial technical submission frameworks
  • Alignment with the Shafafiya program

Healthcare providers were required to begin adopting patient-level costing methodologies and ensure alignment between clinical and financial data systems.

For a detailed overview of the initial framework and compliance timeline, refer to this guide:
👉 DOH Clinical Costing Compliance Guide

What is New in Clinical Costing Roadmap 2026 (V2)?

The 2026 update builds on Version 1.0 by introducing more advanced requirements and standardization measures.

1. Introduction of Clinical Costing Standard Version 2.0

Version 2.0 includes:

  • Updated costing methodologies
  • Refined allocation principles
  • Improved alignment with financial reporting structures

This ensures higher accuracy in attributing both direct and indirect costs at the patient level.

2. Enhanced Technical Specifications

The roadmap introduces updated technical documentation, including:

  • Revised data structures
  • Improved submission formats
  • Expanded technical guidelines

These updates aim to ensure consistency and reduce discrepancies in submitted data.

3. Strengthened Validation and Compliance Requirements

Regulatory oversight is expected to increase with:

  • Enhanced data validation rules
  • Stricter audit requirements
  • Greater emphasis on data accuracy and completeness

Healthcare providers must ensure that submitted costing data is fully reconcilable with financial systems.

4. Expanded Documentation and Guidance

Version 2.0 is supported by:

  • Detailed implementation guidelines
  • Updated technical FAQs
  • Clarifications on costing methodologies

This helps providers better interpret and apply regulatory requirements.

5. Alignment with Value-Based Healthcare Objectives

The updated roadmap continues to support the UAE’s transition toward value-based healthcare by enabling:

  • Cost transparency
  • Performance benchmarking
  • Outcome-based decision-making

Who Needs to Comply

The Clinical Costing Roadmap applies to all healthcare providers under DOH Abu Dhabi, including:

  • Hospitals
  • Clinics
  • Day surgery centers

All applicable entities are required to implement compliant patient-level costing systems and adhere to submission requirements.

Operational and Strategic Implications

Operational Impact

  • Increased need for accurate cost allocation
  • Requirement for system integration (EMR + ERP)
  • Enhanced data validation processes

Strategic Impact

  • Improved visibility into cost drivers
  • Better financial and operational decision-making
  • Alignment with regulatory and payer expectations

Preparing for Clinical Costing Roadmap 2026

To ensure compliance and readiness, healthcare providers should:

  • Review and update existing costing methodologies
  • Ensure integration between clinical and financial systems
  • Validate data accuracy and reporting structures
  • Align internal processes with DOH requirements

Conclusion

The DOH Clinical Costing Roadmap 2026 (V2) represents a significant advancement in the UAE’s healthcare financial framework. By enhancing accuracy, standardization, and compliance requirements, the roadmap enables healthcare providers to move beyond basic implementation toward mature, data-driven cost management practices.

As regulatory expectations continue to evolve, healthcare organizations will need to adopt more structured and technology-driven approaches to meet compliance and reporting requirements. Implementing a reliable clinical costing software can support this transition by enabling accurate cost allocation, streamlined data integration, and improved audit readiness.

Organizations that proactively align with these updates will be better positioned to ensure compliance, improve operational efficiency, and support long-term value-based healthcare objectives.

Our Approach

At RITS, we partner closely with healthcare providers to streamline their journey toward compliant and efficient clinical costing. Our software, QC Centra, is designed to deliver precise patient-level costing, seamless system integration, and full alignment with DOH requirements.

But our goal isn’t just compliance—it’s empowering organizations to build a structured, data-driven foundation for sustainable operational and financial success.